Products for Research Use Only
RegisterLogin

MEDI4276

CAT: 0804-HY-177710Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-177710Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
MEDI4276 is a biparatopic tetravalent antibody targeting two nonoverlapping epitopes in subdomains 2 and 4 of the HER2 ecto-domain. MEDI4276 is composed of MEDI4276 Antibody and a cytotoxic payload AZ1508 (HY-128962) linked through site-specific coupling. MEDI4276 exhibits antitumor activity[1].
UNSPSC
12352005
Target
Antibody-Drug Conjugates (ADCs) ; EGFR
Related Pathways
Antibody-drug Conjugate/ADC Related; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[MEDI4276]
References & Citations
[1]Pegram MD, et al. First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody-Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer. Mol Cancer Ther. 2021 Aug;20 (8) :1442-1453.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
ErbB2/HER2

Related Products

CatalogName
HY-P991651MEDI4212

Alternative Products

CatalogName
T9901A-969-01MEDI4276 Antibody
PTX25948Anti-Human CD340/ERBB2/HER2/NEU (MEDI4276)
HY286566-01Research Grade Anti-Human CD340/ERBB2/HER2/NEU (MEDI4276)
A136358Anti-CD340/ERBB2/HER2/NEU (MEDI4276) Biosimilar (Monoclonal, IgG)

Popular Products